• Combo Treatment Could Delay Kidney Failure for Years in Nondiabetic CKD

    11 days ago - By MedPageToday

    Combining the powers of SGLT2 and renin-angiotensin-aldosterone system inhibitor therapy could substantially reduce the risk of kidney failure or death for patients with albuminuric, nondiabetic chronic kidney disease...
    Read more ...